ACRX

Acelrx Pharmaceuticals Inc

No insider bought or sold Acelrx Pharmaceuticals Inc in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow ACRX

ACRX over the last year

No insider buys filed in this year

ACRX after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

18 insider filings since 2016, newest first

ACRXBuy

Mark G Edwards · Director

$45K+11.0%Nov 12

ACRXBuy

Mark G Edwards · Director

$57K+10.0%Mar 12

ACRXBuy

Badri N Dasu · Chief Engineering Officer

$26K+9.0%Mar 4

ACRXBuy

Vincent J. Angotti · CEO

$30K+24.0%Dec 12

ACRXBuy

Pamela P Palmer · Chief Medical Officer

$49K+4.0%Nov 19

ACRXBuy

Mark G Edwards · Director

$58K+13.0%Nov 15

ACRXSell

Badri N Dasu · Chief Engineering Officer

$142K−34.0%Oct 16

ACRXSell

Lawrence G Hamel · Chief Development Officer

$26K−9.0%Oct 16

ACRXSell

Lawrence G Hamel · Chief Development Officer

$31K−10.0%Sep 26

ACRXBuy

Vincent J. Angotti · CEO

$29K+40.0%Aug 7

ACRXBuy

Pamela P Palmer · Chief Medical Officer

$102K+9.0%Aug 6

ACRXBuy

Mark G Edwards · Director

$57K+25.0%Nov 15

ACRXSell

Lawrence G Hamel · Chief Development Officer

$54K−15.0%Oct 3

ACRXSell

Perceptive Advisors LLC · 10% owner

$2.1M−16.0%Jun 21

ACRXSell

Perceptive Advisors LLC · 10% owner

$849K−4.0%Sep 30

ACRXSell

Perceptive Advisors LLC · 10% owner

Howard B Rosen · CEO

Mark G Edwards · Director

$47K+15.0%May 12

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.